Form 4: MapLight Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Jonathan Gillis, CAO and Interim CFO of MapLight Therapeutics, Inc., sold 36,979 shares of common stock on July 15, 2026.
Summary
- Open-market sale: disposed of 5,356 Voting Common Stock at $36.13 ($193,512) on July 15, 2026; holds 175,863 after (Direct).
- Open-market sale: disposed of 4,699 Voting Common Stock at $36.94 ($173,581) on July 15, 2026; holds 171,164 after (Direct).
- Open-market sale: disposed of 6,979 Voting Common Stock at $36.66 ($255,850) on July 16, 2026; holds 164,185 after (Direct).
- Open-market sale: disposed of 1,476 Voting Common Stock at $37.44 ($55,261) on July 16, 2026; holds 162,709 after (Direct).
- Open-market sale: disposed of 600 Voting Common Stock at $36.51 ($21,906) on July 17, 2026; holds 162,109 after (Direct).
- Open-market sale: disposed of 16,969 Voting Common Stock at $37.61 ($638,204) on July 17, 2026; holds 145,140 after (Direct).
- Open-market sale: disposed of 900 Voting Common Stock at $38.17 ($34,353) on July 17, 2026; holds 144,240 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,372,668 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jonathan Gillis — Officer (CAO and Interim CFO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market sale | Voting Common Stock | 5,356 | $36 | $193.5K | 175,863 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 4,699 | $37 | $173.6K | 171,164 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 6,979 | $37 | $255.9K | 164,185 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 1,476 | $37 | $55.3K | 162,709 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 600 | $37 | $21.9K | 162,109 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 16,969 | $38 | $638.2K | 145,140 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 900 | $38 | $34.4K | 144,240 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market sale (5,356 shares) |
| 2026-07-15 | Open-market sale (4,699 shares) |
| 2026-07-16 | Open-market sale (6,979 shares) |
| 2026-07-16 | Open-market sale (1,476 shares) |
| 2026-07-17 | Open-market sale (600 shares) |
| 2026-07-17 | Open-market sale (16,969 shares) |
| 2026-07-17 | Open-market sale (900 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Jonathan Gillis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.